Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$6.00
0.081.35%
At close: Jan 14, 4:00 PM EST
$6.06
0.06441.07%
After Hours: 7:56 PM EST
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Savara (SVRA) stock?
You can purchase shares of Savara (NASDAQ:SVRA) through any online brokerage.
Who are Savara (SVRA) competitors?
Other companies in Savara’s space includes: ARS Pharmaceuticals Inc (NASDAQ:SPRY), MoonLake Immunotherapeutics (NASDAQ:MLTX), Immatics NV (NASDAQ:IMTX), Day One Biopharmaceuticals Inc (NASDAQ:DAWN) and CareDx Inc (NASDAQ:CDNA).
What is the forecast, or price target, for Savara (SVRA) stock?
Savara has a consensus price target of $8.00.
What is the current price for Savara (SVRA)?
The stock price for Savara (NASDAQ: SVRA) is $6.0644 last updated January 14, 2026 at 7:56 PM EST.
Does Savara (SVRA) pay a dividend?
There are no upcoming dividends for Savara.
When is Savara (NASDAQ:SVRA) reporting earnings?
Savara does not have any upcoming earnings scheduled.
Is Savara (SVRA) going to split?
There is no upcoming split for Savara.
What sector and industry does Savara (SVRA) operate in?
Savara is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
